To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years
Conditions:   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis Intervention:   Biological: DTaP-IPV combination vaccine Sponsor:   Boryung Biopharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2020 Category: Research Source Type: clinical trials

Maternal Pertussis Wholecell Responses
Condition:   Pertussis Interventions:   Biological: Standard of care vaccines;   Biological: Boostagen, (BioNet-Asia) Sponsors:   St George's, University of London;   Medical Research Council;   University of British Columbia;   Public Health England;   MU-JHU CARE;   BioNet-Asia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials